Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Arena Pharmaceuticals Inc. (ARNA)

41.15 -0.37 (-0.89%)

10-17 16:00

Open:

41.52

Pre. Close:

41.52

High:

41.87

Low:

40.55

Volume:

139,724

Market Cap:

2031M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

41.932 - 42.143

42.143 - 42.317

Low:

40.067 - 40.288

40.288 - 40.47

Close:

40.824 - 41.173

41.173 - 41.46

Technical analysis  (as of: 2018-10-17 4:31:36 PM)

Overall:

      

Stoxline posted a BUY today, downgraded from strong buy. But this stock still is very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 52.26     One year: 56.59

Support:

Support1: 38.75    Support2: 32.24

Resistance:

Resistance1: 44.74    Resistance2: 48.45

Pivot:

42.13

Moving Averages:

MA(5): 40.30     MA(20): 42.40

MA(100): 42.15     MA(250): 38.59

MACD:

MACD(12,26): -0.25     Signal(12,26,9): 0.13

%K %D:

%K(14,3): 19.73     %D(3): 14.63

RSI:

RSI(14): 49.25

52-Week:

High: 50.05  Low: 24.33  Change(%): 50.7

Average Vol(K):

3-Month: 55597  10-Days 62899

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ARNA has closed above bottom band by 41.4%. Bollinger Bands are 78.8% wider than normal. The large width of the bands suggest high volatility as compared to ARNA's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

2018-10-08T16:01:00-04:00
Arena Pharmaceuticals Presented Phase 2 Clinical Data for Etrasimod in Ulcerative Colitis at the American College of Gastroenterology Annual Meeting

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

49.35

Shares Float (M)

46.76

% Held by Insiders

% Held by Institutions

82.40

Shares Short (K)

3249

Shares Short Prior Month (K)

Stock Financials

EPS

-2.440

EPS Est. Current Year

-2.940

EPS Est. Next Year

-2.730

EPS Est. Next Quarter

-0.660

Forward EPS

-3.211

Book Value (p.s.)

3.480

PEG Ratio

0.66

Profit Margin

Operating Margin

-424.90

Return on Assets (ttm)

-26.6

Return on Equity (ttm)

-34.2

Qtrly Rev. Growth

110.4

Gross Profit (p.s.)

0.101

Sales Per Share

EBITDA (p.s.)

-0.595

Qtrly Earnings Growth

Operating Cash Flow (M)

-91.96

Levered Free Cash Flow (M)

-69.63

Valuation

P/E

-16.86

P/E Growth Ratio

-0.01

P/BV

11.82

P/S

3626343936.00

P/CF

-22.08

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-06-19

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.